UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 541

Sortiert nach

ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders

Journal of thrombosis and haemostasis, 2010-09, Vol.8 (9), p.2063-2065

2010

Volltextzugriff (PDF)

Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation

Journal of thrombosis and haemostasis, 2011-06, Vol.9 (6), p.1143-1148

2011

Volltextzugriff (PDF)

Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient‐level meta‐analysis

Journal of thrombosis and haemostasis, 2010-11, Vol.8 (11), p.2436-2442

2010

Volltextzugriff (PDF)

Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)

Journal of thrombosis and haemostasis, 2012-06, Vol.10 (6), p.1019-1025

2012

Volltextzugriff (PDF)

Bleeders, bleeding rates, and bleeding score

Journal of thrombosis and haemostasis, 2013-06, Vol.11, p.142-150

2013

Volltextzugriff (PDF)

Interlaboratory variability in the measurement of direct oral anticoagulants: results from the external quality assessment scheme

Journal of thrombosis and haemostasis, 2018-03, Vol.16 (3), p.565-570

2018

Volltextzugriff (PDF)

Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire

Journal of thrombosis and haemostasis, 2009-08, Vol.7 (8), p.1418-1421

2009

Volltextzugriff (PDF)

Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study

International journal of laboratory hematology, 2016-02, Vol.38 (1), p.42-49

2016

Volltextzugriff (PDF)

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism

Journal of thrombosis and haemostasis, 2018-10, Vol.16 (10), p.1994-2002

2018

Volltextzugriff (PDF)

A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM‐1 VWD)

Journal of thrombosis and haemostasis, 2006-04, Vol.4 (4), p.766-773

2006

Volltextzugriff (PDF)

External validation of the DASH prediction rule: a retrospective cohort study

Journal of thrombosis and haemostasis, 2017-10, Vol.15 (10), p.1963-1970

2017

Volltextzugriff (PDF)

Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment‐related risk factors

Journal of thrombosis and haemostasis, 2014-08, Vol.12 (8), p.1266-1273

2014

Volltextzugriff (PDF)

Thrombophilic mutations and cardiovascular disease: the case is still open

Journal of thrombosis and haemostasis, 2010-10, Vol.8 (10), p.2113-2115

TOSETTO, A.

2010

Volltextzugriff (PDF)

The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study

Journal of thrombosis and haemostasis, 2005-12, Vol.3 (12), p.2619-2626

2005

Volltextzugriff (PDF)

Different bleeding risk in type 2A and 2M von Willebrand disease: a 2‐year prospective study in 107 patients

Journal of thrombosis and haemostasis, 2012-04, Vol.10 (4), p.632-638

2012

Volltextzugriff (PDF)

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: reply

Journal of thrombosis and haemostasis, 2018-12, Vol.16 (12), p.2539-2540

2018

Volltextzugriff (PDF)

Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data

Journal of thrombosis and haemostasis, 2015-05, Vol.13 (5), p.775-781

2015

Volltextzugriff (PDF)

Reduced von Willebrand factor survival in von Willebrand disease: pathophysiologic and clinical relevance

Journal of thrombosis and haemostasis, 2009-07, Vol.7, p.71-74

2009

Volltextzugriff (PDF)

Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis

BMJ (Online), 2011-02, Vol.342, p.d813

2011

Volltextzugriff (PDF)

European retrospective study of real‐life haemophilia treatment

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-01, Vol.23 (1), p.105-114

2017

Volltextzugriff (PDF)

How to estimate bleeding risk in mild bleeding disorders

Journal of thrombosis and haemostasis, 2007-07, Vol.5 (s1), p.157-166

2007

Volltextzugriff (PDF)

Bleeding scores in inherited bleeding disorders: clinical or research tools?

Haemophilia : the official journal of the World Federation of Hemophilia, 2008-05, Vol.14 (3), p.415-422

2008

Volltextzugriff (PDF)

Magnetic resonance imaging and ultrasound evaluation of "healthy" joints in young subjects with severe haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-05, Vol.19 (3), p.e167-e173

2013

Volltextzugriff (PDF)

The predictive value of factor VIII/factor IX levels to define the severity of hemophilia: communication from the SSC of ISTH

Journal of thrombosis and haemostasis, 2018-10, Vol.16 (10), p.2106-2110

2018

Volltextzugriff (PDF)

Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism

Annals of internal medicine, 1999-04, Vol.130 (8), p.643

1999

Volltextzugriff (PDF)

1 – 25 von 541

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(490)
Mit Volltextzugriff
(473)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders

Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation

Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient‐level meta‐analysis

Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)

Bleeders, bleeding rates, and bleeding score

Interlaboratory variability in the measurement of direct oral anticoagulants: results from the external quality assessment scheme

Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire

Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism

A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM‐1 VWD)

External validation of the DASH prediction rule: a retrospective cohort study

Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment‐related risk factors

Thrombophilic mutations and cardiovascular disease: the case is still open

The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study

Different bleeding risk in type 2A and 2M von Willebrand disease: a 2‐year prospective study in 107 patients

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: reply

Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data

Reduced von Willebrand factor survival in von Willebrand disease: pathophysiologic and clinical relevance

Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis

European retrospective study of real‐life haemophilia treatment

How to estimate bleeding risk in mild bleeding disorders

Bleeding scores in inherited bleeding disorders: clinical or research tools?

Magnetic resonance imaging and ultrasound evaluation of "healthy" joints in young subjects with severe haemophilia A

The predictive value of factor VIII/factor IX levels to define the severity of hemophilia: communication from the SSC of ISTH

Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism

Suchergebnisse filtern